ArticleJAMA internal medicine2023

Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels.

Elvira D'Andrea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.